What do you get when you undertake a cost-benefit analysis of new therapies when prices have yet to be established… Read more »
Tag: oit
Longer Trial Increased Level of Tolerance to AR101 Peanut Therapy
By extending the peanut biologic oral immunotherapy known as AR101 by 28 weeks, a new study finds that a majority… Read more »
FARE’s Chief Medical Advisor on Why Standardizing OIT is Needed Now
A Q&A with FARE about the consensus the non-profit hopes to achieve at a fall summit on OIT.
Study Favoring Avoidance Over Food Allergy OIT Ignites Controversy
A systematic review of peanut oral immunotherapy that compared 12 controlled studies has brought a longstanding “pro or con” debate… Read more »
Boiled Peanut Safe and Effective to Use During OIT, Study Finds
Using boiled peanut protein in oral immunotherapy treatment (OIT) is safe and effective, with fewer gastrointestinal symptoms compared to using… Read more »
Long-Term Peanut OIT Has Lasting Benefits, Study Reveals
In a long-term follow-up with 55 peanut-allergic children who had undergone oral or sublingual immunotherapy, 89 percent of patients followed… Read more »
NEJM Publishes Positive Study Data on OIT Biologic for Peanut Allergy
The positive results of a pivotal Phase 3 study of a peanut biologic oral immunotherapy known as AR101 were published… Read more »
Xolair Gains “Breakthrough” Status to Be Developed as Food Allergy Treatment
The FDA has given its “breakthrough therapy designation” to omalizumab, known by the brand Xolair, to be developed as a… Read more »
Allergists Excited for Peanut Therapy That’s in Line for Approval
Hundreds of allergists turned out to see Dr. Stacie Jones present highly anticipated study results at the AAAAI/WAO joint congress… Read more »
Reality Check: The Facts Beyond the Hype over Peanut Allergy and Probiotics
Three experts dispute the claims that a new probiotic therapy is a breakthrough for peanut allergy.